Centrus Energy Corp. (LEU)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,959	1,092	853	472	700	278
Market Cap Growth	356.36%	28.05%	80.61%	-32.50%	151.22%	328.00%
Enterprise Value	3,556	1,069	850	488	637	244
Last Close Price	232.39	66.61	54.41	32.48	49.91	23.13
PE Ratio	37.75	14.92	10.11	9.32	5.17	48.01
PS Ratio	9.02	2.47	2.66	1.61	2.35	1.13
PB Ratio	11.78	6.77	26.41	-6.37	-4.93	-0.87
P/TBV Ratio	11.84	8.29	-	-	-	-
P/FCF Ratio	37.14	33.20	113.72	23.73	14.34	4.24
P/OCF Ratio	34.73	29.52	93.73	22.93	13.99	4.15
EV/Sales Ratio	8.14	2.42	2.65	1.66	2.13	0.99
EV/EBITDA Ratio	35.78	14.48	9.85	6.39	4.41	4.04
EV/EBIT Ratio	40.23	16.96	10.73	7.31	4.68	4.59
EV/FCF Ratio	33.36	32.48	113.32	24.53	13.05	3.72
Debt / Equity Ratio	1.20	3.39	5.48	-2.29	-0.95	-0.36
Debt / EBITDA Ratio	4.32	7.34	2.05	2.20	0.93	1.85
Debt / FCF Ratio	4.03	16.63	23.61	8.53	2.75	1.77
Asset Turnover	0.44	0.47	0.43	0.46	0.56	0.53
Inventory Turnover	1.08	1.41	0.81	1.17	2.36	2.31
Quick Ratio	1.79	2.17	0.53	0.49	0.57	0.50
Current Ratio	2.59	2.93	1.46	1.31	1.19	1.11
Return on Equity (ROE)	48.11%	75.58%	-	-	-	-
Return on Assets (ROA)	5.57%	4.17%	6.59%	6.53%	16.05%	7.06%
Return on Capital (ROIC)	10.65%	8.58%	32.45%	94.89%	-	-
Return on Capital Employed (ROCE)	10.60%	8.40%	24.40%	26.10%	75.90%	44.30%
Earnings Yield	2.65%	6.70%	9.90%	11.05%	25.01%	19.53%
FCF Yield	2.69%	3.01%	0.88%	4.21%	6.98%	23.59%
Buyback Yield / Dilution	-7.13%	-5.63%	-3.42%	-7.99%	-37.10%	-5.82%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q